Dr. Resar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-955-3142Fax+1 410-614-8601
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1992- Johns Hopkins UniversityResidency, Pediatrics, 1986 - 1989
Medical College of WisconsinClass of 1986
Certifications & Licensure
MD State Medical License 1989 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Expanded Access Protocol Using HBOC-201
Roles: Contact
Publications & Presentations
PubMed
- A Propensity-Matched Cohort Study of Intravenous Iron versus Red Cell Transfusions for Preoperative Iron-Deficiency Anemia.Una E Choi, Ryan C Nicholson, Ananda J Thomas, Elizabeth P Crowe, John A Ulatowski
Anesthesia and Analgesia. 2024-11-01 - Gastrointestinal Bleeding and Survival After a Nadir Hemoglobin <3.0 g/dL in 2 Jehovah's Witness Patients: A Case Report.Matthew B Sklar, Tymoteusz J Kajstura, Samantha L Vogt, Christy Gray, John A Ulatowski
A&A Practice. 2024-08-01 - 1 citationsGreater Than Sevenfold Return on Investment for a Comprehensive Patient Blood Management Program With Equivalent or Improved Outcomes.Steven M Frank, Nadia B Hensley, Ananda J Thomas, Clarita G Dawson, Linda M S Resar
Anesthesia and Analgesia. 2024-06-01
Abstracts/Posters
- High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPNLinda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational BurdenLinda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALLLinda Resar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Study Discover Novel Cell Signaling Pathway for Deadly Pancreatic CancersApril 25th, 2023
- Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021
Bloodless Medicine | Hazel's StoryJuly 3rd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
